As of 2024-12-14, the Fair Value of Scandion Oncology A/S (SCOL.ST) is -1.18 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.09 SEK, the upside of Scandion Oncology A/S is -1,420.06%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -8.18 | -12.18 | -16.27 | -14.71 | -76.70 | -25.61 |
| YoY growth | -707.88% | -48.90% | -33.53% | 9.59% | -421.48% | -240.44% |
| Market Cap (mil) | 21.01 |
| P/E | |
| Forward P/E |
| EPS | -0.15 |
| Avg earnings growth rate | -240.44% |
| TTM earnings | -35.88 |